...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
Becton, Dickinson and Company logo
BDX NYSE 🇺🇸 US
Becton, Dickinson and Company
Healthcare
Not a Dip
Price Zone: Consider Trimming
🔒 Full AI Analysis — Pro
16Score
DipBuster Score™
$184.74 $2.88 (-1.54%) Live price · Source: Yahoo
52-Week Position
$127.59 87% of range $193.07
Beta
0.258
Low vol
Dividend
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.258
52W High$193.07
52W Low$127.59
DipBuster Brief Key signals at a glance
Zone: Consider Trimming
Bearish
Near 52-Week High — Asymmetric Risk
At 87% of its annual range the stock is close to its peak. New buyers face limited upside and meaningful downside if sentiment shifts.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio
Mkt CapN/A
52W Position87% of range
EV/EBITDA
Cash Flow
FCF Yield
FCF / Share
Op. Cash Flow
Margins
Gross Margin
Op. Margin
Net Margin
Balance Sheet
Cash
Total Debt
Net Cash
Dividend
Yield
Annual / shNone
Beta0.258
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts

Recent director dealings and insider transactions at Becton, Dickinson and Company (BDX), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date Insider Type Shares
2026-08-26 Feld Michael SELL 165
2026-08-20 Feld Michael SELL 1,049
2026-08-13 Polen Thomas E Jr SELL 43,278
2026-08-13 Polen Thomas E Jr SELL 4,152
2026-08-13 Polen Thomas E Jr SELL 39,126
2026-08-13 Polen Thomas E Jr BUY 43,278
2026-08-11 Goette Roland SELL 2,438
2026-08-06 Huffines Robert Luther BUY 189
2026-08-06 Byington Carrie L BUY 94
2026-07-27 Feld Michael SELL 75

Valuation

P/E RatioN/A
Market CapN/A
Beta0.258
Dividend/yrNone
52W High$193.07
52W Low$127.59

52-Week Range

$127.59Now$193.07
87% through annual range
From 52W High−4.3%
From 52W Low+44.8%
📖 Plain English Summary
Becton, Dickinson and Company is at 87% of its 52-week range. Beta 0.258 — tends to move less than the market.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for BDX 🟢 Bullish ⬜ Neutral 🔴 Bearish
🤖
DipBuster AI Analysis — BDX
Heuristic · balance sheet, insider filings, price data, academic research

Becton, Dickinson and Company — DipBuster Score 16/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track Becton, Dickinson and Company free

Add BDX to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Open Account →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 5/25
Momentum & Volume 6/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
6 /100 · NEUTRAL
dip depth 3/25
oversold rsi 0/25
mean reversion 3/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
Not a Dip
DipBuster Score: 16/100
📊 Run a full check in the AI analysis tab for a deeper look.
Company Profile

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supp…

Sector Healthcare
Market 🇺🇸 US
CEO Thomas E. Polen Jr.
Staff 72,000 employees
Website bd.com

More Healthcare stocks

UNH UnitedHealth GroupJNJ Johnson & JohnsonABT Abbott LaboratoriesTMO Thermo Fisher ScientificDHR Danaher Corp.MDT Medtronic plcSYK Stryker Corp.BSX Boston ScientificAll Healthcare stocks →